XT
IMMX icon

XTX Topco’s Immix Biopharma IMMX Stock Holding History

XTX Topco’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Sell
40,495
-40,556
-50% -$376K 0.01% 2624
2026
Q1 		$738K Buy
81,051
+34,657
+75% +$255K 0.01% 1683
2025
Q4 		$243K Buy
46,394
+11,241
+32% +$46.3K 0.01% 2256
2025
Q3 		$73.5K Buy
+35,153
New +$84.4K ﹤0.01% 2087
2025
Q2 		– Sell
-12,833
Closed -$21.6K – 2737
2025
Q1 		$21.6K Buy
+12,833
New +$24.2K ﹤0.01% 2126
2024
Q3 		– Sell
-17,663
Closed -$35K – 2319
2024
Q2 		$35K Sell
17,663
-34,534
-66% -$79.3K ﹤0.01% 1547
2024
Q1 		$160K Buy
+52,197
New +$202K 0.02% 1243
2022
Q2 		– Sell
-12,992
Closed -$31K – 968
2022
Q1 		$31K Buy
+12,992
New +$48.2K 0.01% 616

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's IMMX Position: Q2 2026 in Review

XTX Topco reduced its Immix Biopharma (IMMX) stake by 50% in Q2 2026, selling an estimated $376K and leaving 40,495 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #2624.

XTX Topco first reported a position in IMMX in Q1 2022 and has held it in 8 quarters since. The position peaked at $738K in Q1 2026. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • XTX Topco held 40,495 shares of Immix Biopharma worth $418K as of Q2 2026.
  • XTX Topco sold 40,556 Immix Biopharma shares in Q2 2026, an estimated $376K.
  • Immix Biopharma made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2624 holding.
  • XTX Topco first reported a position in Immix Biopharma in Q1 2022 and has held it in 8 quarters since.
  • XTX Topco's Immix Biopharma position peaked at $738K in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.